LTKOSN-transduced lymphocytes (Human Gene Therapy Research Institute)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameLTKOSN-transduced lymphocytes (Human Gene Therapy Research Institute)
Drug Alias NameN/A
ClassificationCell and gene therapy > Gene therapyCell and gene therapy > Cell therapy
Mechanisms of ActionThymidine kinase modulators
TargetsThymidine kinase
Therapy Area/IndicationsHematologic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesHuman Gene Therapy Institute
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesHuman Gene Therapy Institute
Active IndicationsN/A
Inactive IndicationsHematologic Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A